Safety and efficacy of esaxerenone in Japanese hypertensive patients with heart failure with reduced ejection fraction: A retrospective study.
Esaxerenone, a mineralocorticoid receptor blocker (MRB), is a new antihypertensive agent. However, esaxerenone-related data with respect to hypertension with heart failure are limited. We investigated the safety and efficacy of esaxerenone in hypertensive patients with heart failure with reduced eje...
Saved in:
Main Authors: | Togo Iwahana, Yuichi Saito, Sho Okada, Hirotoshi Kato, Ryohei Ono, Yoshio Kobayashi |
---|---|
Format: | article |
Language: | EN |
Published: |
Public Library of Science (PLoS)
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/92ecad5b4f33458babf8d6b28945a78c |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Safety and efficacy of esaxerenone in Japanese hypertensive patients with heart failure with reduced ejection fraction: A retrospective study
by: Togo Iwahana, et al.
Published: (2021) -
Literature reviews of stroke with hypereosinophilic syndrome
by: Ryohei Ono, et al.
Published: (2021) -
Association between early intensive care or coronary care unit admission and post-discharge performance of activities of daily living in patients with acute decompensated heart failure.
by: Masato Kanda, et al.
Published: (2021) -
Features of heart failure with preserved ejection fraction (HFpEF) in diabetic patients with resistant hypertension
by: M. A. Manukyan, et al.
Published: (2021) -
A study of association between heart failure with preserved ejection fraction with hypertension and diabetes mellitus
by: Swapan Sarkar, et al.
Published: (2021)